// App-Quantinova.ai

: Improving accessibility to pancreatic cancer with circulating tumour cell technologies for targeted molecular therapeutics

Researchers

Presenter

  • C. Chew

Principal Investigators

  • S.L. Chan

  • E.S.H. Cheow

  • A.W.C. Kow

  • K. Madhavan

  • S.G. Iyer

  • C.E. Chee

  • G.K. Bonney

Medical Centers

  • iHealthTech, National University of Singapore, Singapore, Singapore

  • Department of Haematology-Oncology, National University Hospital, Singapore

Locations

  • Singapore

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreatic cancer

  • Pancreato-biliary malignancies

  • Solid malignancies

Biomarkers

  • Circulating tumor cells

  • KRAS proto-oncogene, GTPase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved